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Abstract
Background: Molecular mimicry between microbial antigens and host-proteins is one of the etiological enigmas
for the occurrence of autoimmune diseases. T cells that recognize cross-reactive epitopes may trigger autoimmune
reactions. Intriguingly, autoimmune diseases have been reported to be prevalent in tuberculosis endemic
populations. Further, association of Mycobacterium tuberculosis (M. tuberculosis) has been implicated in different
autoimmune diseases, including rheumatoid arthritis and multiple sclerosis. Although, in silico analyses have
identified a number of M. tuberculosis specific vaccine candidates, the analysis on prospective cross-reactive
epitopes, that may elicit autoimmune response, has not been yet attempted. Here, we have employed
bioinformatics tools to determine T cell epitopes of homologous antigenic regions between M. tuberculosis and
human proteomes.
Results: Employing bioinformatics tools, we have identified potentially cross-reactive T cell epitopes restricted to
predominant class I and II alleles of human leukocyte antigens (HLA). These are similar to peptides of
mycobacterial proteins and considerable numbers of them are promiscuous. Some of the identified antigens
corroborated with established autoimmune diseases linked with mycobacterial infection.
Conclusions: The present study reveals many target proteins and their putative T cell epitopes that might have
significant application in understanding the molecular basis of possible T cell autoimmune reactions during M.
tuberculosis infections.
Background
Although, the immune system efficiently discriminates
between self and non-self, the occurrence of autoim-
mune diseases is a testimony to the fact that such discri-
mination may be imprecise [1]. Understanding the
etiology of autoimmune diseases has been a great chal-
lenge to immunologists. The existence of central toler-
ance mechanism ensures the clonal deletion of
autoreactive T cells and B cells. Nonetheless, there are
ample evidences signifying that a considerable number
of such cells can escape these “failsafe” mechanisms
[1,2]. Immunological insults like exposure to pathogenic
bacteria, viruses, aberrant expression of self proteins and
exposure to cryptic antigens, etc., have been implicated
to trigger and amplify the immune reactions that culmi-
nate into autoimmune diseases [3-5]. Antigenic determi-
nants/epitopes present in pathogens, which resemble the
host proteins, can potentially be a threat in activating
the cells of immune system, resulting in autoimmunity
[3,4]. This resemblance is popularly termed as molecular
mimicry.
Many different autoimmune diseases have been
hypothesized to be a result of this mistaken identity. As
a result of molecular mimicry, the immune cells attack
the host tissues [3,5]. The sharing of similar epitopes
between the host and the pathogens may instigate auto-
aggression by stirring autoreactive T cells and B cells.
Usually, autoreactive T cells are quiescent in the
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nity epitopes. Pathogenic organisms express pathogen
associated molecular patterns (PAMPs) that are per-
ceived by the immune system as “danger signals”
through Toll Like Receptors (TLRs) [6]. Hence, the
“TLR licensed” antigen presenting cells (APCs) can
potentially activate the self-reactive T cells, since they
present antigens along with inflammatory signals. Anti-
genic presentation in such a context may result in high
avidity interactions between autoreactive T cells and the
APCs that eventually break tolerance [6]. Antigens like
the pulD protein from Klebsiella sp., nuclear antigen-1
from Epstein-Barr virus and OSP-A from Borrelia sp.
have been associated with diseases like ankylosing spon-
dylitis, systemic lupus erythematosus (SLE) and Lyme
arthritis, respectively [7-9]. Importantly, T cells play a
pivotal role in autoimmune reactions, since they may
directly attack the host tissues or help B cells to produce
autoantibodies [10]. Molecular mimicry has been
demonstrated in T cell specific autoimmune diseases
such as multiple sclerosis (MS), myocarditis, diabetes,
etc. One of the early, classic studies by Strominger’s
group showed that the T cells reacting to immunodomi-
nant peptide of myelin basic protein (MBP) could cross-
react with viral antigens [3].
M. tuberculosis infects about two million people
annually. In TB-endemic areas, it is estimated that
almost one-third of the population is infected with M.
tuberculosis [11]. Interestingly, an abundant presence of
autoimmune diseases has been reported in these popula-
tions [12,13]. TB has been associated with many differ-
ent autoimmune diseases like SLE, rheumatoid arthritis
(RA), MS, etc [4,13-21]. There are ample evidences to
suggest that TB reactive T cells can potentially recog-
nize self antigens [14,17-19,21]. This has been demon-
strated in animal models and in TB affected individuals.
For example, T cells responding to the 65 kDa antigen
of M. tuberculosis have been shown to be present in the
synovia of arthritis patients [14,17]. Hence, during a
chronic state of disease, T cells that cross-react with
mycobacterial and self antigens are activated, leading to
detrimental autoimmune responses. Identification of
such cross-reactive epitopes may be of immense scope
in understanding the pathogenesis of autoimmunity. In
this era of informatics, in silico analyses have identified
a number of M. tuberculosis specific T cell epitopes that
could be potentially used as vaccines [22-25]. However,
it warrants the information on prospective cross-reactive
epitopes that may elicit autoimmune responses. Cyto-
toxic CD8 T cells and helper CD4 T cells recognize
peptides in the context of HLA class I and class II mole-
cules, respectively. Both the subsets have been impli-
cated in mediating autoimmune responses. Here, we
have used bioinformatics tools to identify M.
tuberculosis and human cross-reactive T cell epitopes,
restricted to predominant HLA class I and class II
alleles [26,27]. Interestingly, we could identify several
epitopes exhibiting similarity between human and M.
tuberculosis proteins that may be molecular triggers of
autoimmunity.
Methods
Alleles used in the study
Predominantly occurring MHC (major histocompatibil-
ity complex) alleles in human population for HLA class
I (A*01:01, A*02:01, A*03:01, A*11:01, A*24:02, B*07:02,
B*08:01) and HLA class II (DRB1*01:01, DRB1*03:01,
DRB1*04:01, DRB1*07:01, DRB1*08:02, DRB1*11:01,
DRB1*13:02, DRB1*15:01) were chosen for the study
[26-30].
Programs and databases
Netmhc2.2
NetMHC 2.2 server predicts binding of peptides to var-
ious human HLA class II alleles using artificial neural
networks (ANNs) [30].
Netmhc3.0
NetMHC 3.0 server predicts binding of peptides to a
number of different HLA class I alleles using artificial
neural networks and weight matrices [30].
HAMAP
HAMAP (High-quality Automated and Manual Annota-
tion of microbial Proteomes) automatically annotates a
significant percentage of proteins originating from
microbial genome sequencing projects [31]. HAMAP
uses annotation templates for protein families to propa-
gate annotations to all members of manually defined
protein families.
Expasy
Expasy (Expert Protein Analysis System), is a proteomics
server and allows browsing through a number of data
bases as well as other cross-referenced ones [32]. It also
allows access to many analytical tools for the identifica-
tion of proteins, analysis of their sequence and the pre-
diction of tertiary structure.
UniProt
UniProt is the world’s most comprehensive catalogue of
information on proteins [33]. It is a central repository of
protein sequences and functions created by joining the
information contained in UniProt/Swiss-Prot/TrEMBL.
The UniProt knowledgebase (UniProtKB) is the central
hub for the collection of functional information on pro-
teins, with accurate, consistent and rich annotation.
Identification and analysis of homologous M. tuberculosis
peptides in humans
Sequences of curated proteins of M. tuberculosis were
obtained from UNIPROT database employing HAMAP
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tuberculosis H37Rv were selected from the database.
The four classifications of the proteins of M. tuberculo-
sis, namely structural, secretory, antigenic and metabolic
have been directly adopted from UNIPROT database.
The proteins chosen were compared for similarity with
the human proteome using BLAST program [34] from
ExPASY server. Based on the BLAST results, regions of
nine or more amino acids (small peptides) that were
similar between the human and M. tuberculosis proteins
were selected for further analysis. The selected human
peptides were assessed for binding to different predomi-
nant HLA class I and class II alleles by using the
NetMHC server. IC50 values were selected based on the
binding scores of peptide core regions (9 amino acids
length) to each allele. The peptides were classified based
on predicted IC50 values as strong binders (IC50 ≤ 500),
weak binders (500 ≤ IC50 ≤ 5000) and non-binders (IC50
≥ 5000) [35-37]. The results were then analyzed by con-
sidering the binding affinity of peptides to HLA alleles,
nature of antigens, allelic associations of autoimmune
diseases and tuberculosis.
Results
Mycobacterial proteome contains T cell epitopes that
cross-react with human proteins
The analysis of the data obtained from the search
between M. tuberculosis and human proteomes revealed
considerable similarities in sequences. Many regions,
that were part of metabolic proteins, were homologous
(Additional file 1). A total of 460 similar regions of 9 or
more amino acids were identified. We then utilized in
silico tools to analyze the ability of these peptides to
bind to different HLA class I and class II alleles. Any
such common peptide that had a binding score of IC50
< 5000 was considered as a HLA-binder and thus was
likely to be a T cell epitope. Further, peptides having an
IC50 of ≤ 500 were considered to be strong binders
[35-37]. We found considerable number of peptides
(epitopes henceforth) binding to HLA class I and class
II alleles (Figure 1). Our analysis revealed that the great-
est number of CD4 T cell epitopes were restricted to
DRB1*01:01 (291) followed by DRB1*07:01 (229) and
DRB1*15:01 (191) (Figure 1). Intriguingly, DRB1*15:01 is
also a susceptibility allele for tuberculosis [38,39]. The
analysis of CD8 epitopes indicated maximum (84) num-
ber of peptides binding to allele A*02:01 followed by 81
for A*11:01 and 62 for A*03:01 (Figure 1).
The mycobacterial proteins for this study were classified
into four different categories; antigenic, secretory, struc-
tural and metabolic proteins. The HLA binding analysis
showed that the largest fraction of CD4 T cell epitopes
was from metabolic proteins (Figure 2 and 3). For
almost all the alleles analyz e di nt h ec u r r e n ts t u d y ,
metabolic peptides represented > 80% of the total CD4
T cell epitopes obtained for that particular HLA allele.
However, the absolute number of epitopes restricted to
each allele varied greatly (Figure 2). The highest number
of epitopes homologous to antigenic, structural and
metabolic proteins were restricted to DRB1*01:01 (Fig-
ure 2). Interestingly, although most of the alleles had
equivalent fractions of CD4 T cell epitopes from meta-
bolic proteins, the relative representation of other cate-
gories of epitopes varied considerably (Figure 2 and 3).
Highest fractions of antigenic, structural and secretory
epitopes were noted for DRB1*03:01, DRB1*01:01, and
DRB1*13:02, respectively (Fi g u r e3 ) .N e x t ,w ea n a l y z e d
the fraction of strong binders among the total epitopes
belonging to the different categories of proteins. We
considered peptides with predicted IC50 value ≤ 500 as
strong binders. Although, a majority of the homologous
peptides were weak binders, a fraction of about 20%-
40% were of higher affinities (Figure 4). We next ana-
lyzed for the presence of promiscuous epitopes among
the HLA binding peptides. A peptide that could bind
three or more HLA alleles was considered promiscuous.
We could identify a total of 242 promiscuous peptides
restricted to HLA class II molecules (Additional file 1).
Interestingly, most of the promiscuous peptides (200)
were from the metabolic proteins.
One of the most striking observations was that the
total number of peptides binding to HLA class I were
considerably lesser than HLA class II alleles (Figure 1).
Nevertheless, the homologous peptides screened from
the different classes of proteins (metabolic, antigenic,
structural and secretory), were abundantly restricted to
certain HLA alleles (Figure 5). For instance, allele
A*02:01 bound to the highest number of antigenic
(eight) and metabolic epitopes (70). Further, A*11:01
and B*07:02 indicated binding to highest numbers (21
and 19) of peptides from structural class of antigens
(Figure 5). None of the HLA alleles bound to the homo-
logous epitopes were from secretory antigens. Among
the various HLA class I alleles examined, least number
of CD8 epitopes exhibited binding to A*01:01 (Figure 1).
Interestingly, similar to CD4 T cell epitopes, most of the
peptides that were restricted to HLA class I molecules
were from the metabolic proteins of M. tuberculosis
(Figure 5 and 6). However, there was profound differ-
ence in the relative representative fractions of peptides
from different classes of proteins. Peptides from all the
three different classes of proteins bound to majority of
the tested HLA class I or II alleles. Nevertheless, just
two classes of peptides displayed binding to majority of
HLA class I alleles (Figure 6). Further, we analyzed the
fraction of strong binders among the total peptides for
each class of proteins (Figure 7). Similar to HLA class II
molecules, majority of the HLA class I alleles showed
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for A*11:01 and structural peptides for A*03:01. Next
we analyzed the occurrence of promiscuous CD8 T cell
peptides among the autoantigenic epitopes similar to M.
tuberculosis proteins (Additional file 2). Our analysis for
promiscuous epitopes revealed that although there were
fewer promiscuous CD8 T cell epitopes (44), compared
to CD4 T cell epitopes (242), most of them were from
the metabolic proteins (26) (Additional file 1, 2).
Having recognized the possible autoreactive CD4 and
CD8 T cell epitopes, we next addressed whether the
host antigens containing cross-reactive epitopes had any
known associations in autoimmune reactions. We iden-
tified that some of the host proteins (sharing similarity
with M. tuberculosis proteins) were known to be impli-
cated in diseases like MS, RA, Stiff-man syndrome, etc
[4,19,40]. MS is an autoimmune demyelinating disorder
that severely compromises patients. The precise etiology
for the onset of the disease remains obscure. One of the
hypotheses that explain the initiation of the disease is
the occurrence of antecedent infections that ultimately
lead to the pathogenesis of MS [4,41]. Intriguingly, indi-
viduals positive for HLA-DRB1*15:01 are known to be
susceptible to both MS and tuberculosis [39,41]. One of
the earlier observations suggested the presence of T
cells in MS patients that cross-react to mycobacterial
heat shock proteins (HSP) [18,19,21,41]. Our analysis
showed several peptides from mycobacterial HSP60
(also known as HSP65) homologous to human HSP60
and it relatives, to bind to many different alleles (Table
1). One particular peptide, KPLVIIAEDVD-
GEALSTLVLN, promiscuously bound to many alleles
including HLA-DRB1*15:01 with high affinity. This is
suggestive of the fact that such cross-reactive epitopes
may initiate the pathogenesis of MS. Another autoim-
mune disease that has been frequently associated with
the occurrence of tuberculosis is RA [14,15,17]. Intrigu-
ingly, HSP60 of M. tuberculosis is also implicated in the
pathogenesis of RA [14,15,17]. Our analysis also concurs
with this hypothesis (Table 1). There are reports that
suggest the presence of HSP60 reactive T cell clones
which can also be reactive to the cartilage in the synovia
of RA patients [14]. Hence, HSP60 cross reactive epi-
topes may play a significant role in the etiology of RA
and MS. Further, we could also identify many T cell epi-
topes from different antigens like gephyrin, triosepho-
sphate isomerase, etc., which are associated with Stiff-
man syndrome, arthritis, etc. The putative autoimmune
epitopes with the restricting alleles for known autoanti-
gens that shared sequence similarity with M. tuberculo-
sis proteins are listed in Table 1. The results discussed
in the current section (Table 1) were solely derived
from proteins known to be linked with autoimmune dis-
eases [4,14-18,20]. However, other host antigens, whose
Figure 1 Identification of HLA class I and II restricted T cell epitopes from host proteins that shared similarity with M. tuberculosis
antigens. Protein sequences of M. tuberculosis were subjected to BLAST search with the human proteome for identifying similarity regions. The
peptides were analyzed for HLA binding for predominantly occurring HLA class I and II alleles using NetMHC server as described in methods.
Peptides binding to HLA class I and class II molecules were considered to be CD8 T cell and CD4 T cell epitopes respectively. The peptides were
classified based on predicted IC50 value as strong binders (IC50 ≤ 500), weak binders (500 ≤ IC50 ≤ 5000) and non-binders (IC50 ≥ 5000). The total
number of binders (strong and weak) for each allele is represented as bar diagrams for (A) HLA class II and (B) HLA class I molecules.
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may be involved in the etiology of many other autoim-
mune diseases that need to be clinically verified.
Disscusion
Molecular mimicry between antigenic determinants pre-
sent in pathogenic organisms and host proteins could
potentially trigger autoimmune reactions [42]. Interest-
ingly, many mycobacterial antigens have been associated
with autoimmune diseases [14,16,17]. This prompted us
to investigate the occurrence of peptides in mycobac-
teria that share sequence similarity with human anti-
gens; and identify T cell epitopes that probably would
be responsible for autoimmunity.
Although, in silico tools have been used in the past to
examine molecular mimics in other diseases [5]; the
knowledge of such epitopes from mycobacteria still
needs to be explored. Here, utilizing in silico methods,
we have identified potential autoreactive CD4 and CD8
T cell epitopes that may act as molecular mimics and
result in autoimmune response during M. tuberculosis
infection. The following major findings have emerged
from the present study: (i) there is an extensive number
of potentially autoreactive CD4 and CD8 T cell epitopes
that are similar to peptides of mycobacterial antigens;
(ii) the majority of such epitopes are similar to the anti-
gens from the metabolic proteins of mycobacteria; (iii) a
considerable number of promiscuous CD4 T cell epi-
topes could be detected; (iv) some of the identified anti-
gens were corroborated with established autoimmune
diseases linked with mycobacterial infection, thus vali-
dating the approach. We believe that this study would
be a suggestive starting point for future investigation
that whether mycobacterial infections and molecular
mimics may elicit T cell autoimmune reactions.
Autoimmune reactions occur as a consequence of the
breakdown of self-tolerance. Even though the immune
system has central and peripheral tolerance mechanisms
Figure 2 CD4 T cell epitopes of host proteins share resemblance with different classes of M. tuberculosis antigens. The absolute number
of host-peptides restricted to different HLA class II alleles that showed similarity with the different classes of mycobacterial proteins is
represented as pie charts for (A) antigenic; (B) structural; (C) metabolic proteins of M. tuberculosis.
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occurrence of autoimmune diseases signifies that this
may not totally eliminate the presence or detrimental
activity of host reactive T cells [6]. Autoimmune dis-
eases develop as a result of multifactorial influences like
genetic, hormonal, and environmental factors [43,44].
One of these key elements that substantially influence
the development of autoimmunity is the occurrence of
antecedent infections [45]. Almost every autoimmune
disease investigated is assumed to be linked to one or
more such infections. One of the classical evidences
arguing for this hypothesis is the autoimmune acute
rheumatic fever, which is associated with the infection
with Streptococcus pyogenes. Molecular resemblance
between the bacterial M-protein and human glycopro-
teins results in a breakdown of self-tolerance [46]. The
molecular mimicry hypothesis proposes that shared epi-
topes between the host and pathogen can break toler-
ance and elicit autoreactivity. The degeneracy of antigen
recognition by the T cell receptor may also help in such
cross-reactivity [47]. Similarly, pathogen specific antibo-
dies also can cross-react with host proteins [47]. Hence,
molecular mimicry and consequent epitope spreading is
now a generally accepted phenomenon influencing auto-
immune reactions [3,42,45,47]. The idea of molecular
mimicry was strongly put forward by Fujinami and
Figure 3 The relative fractions of autoreactive CD4 T cell epitopes exhibiting similarity with different categories of antigens of M.
tuberculosis. Bar diagram indicates the relative percentages of HLA class II binders from host-antigens sharing sequence corresponding to
different categories of antigenic proteins of M. tuberculosis.
Figure 4 A considerable fraction of peptides from autoantigens demonstrate strong HLA class II binding. Bar diagram depicts the
percentage of strong binders (IC50 ≤ 500) among the total binders from host peptides that shared similarity to M. tuberculosis antigens.
Babu Chodisetti et al. BMC Immunology 2012, 13:13
http://www.biomedcentral.com/1471-2172/13/13
Page 6 of 10Figure 5 CD8 T cell epitopes of host antigens display similarity with different classes of M. tuberculosis antigens. The absolute number
of host-peptides restricted to different HLA class I alleles that showed similarity with the different classes of M. tuberculosis proteins is
represented as pie charts for (A) antigenic; (B) structural; (C) metabolic proteins.
Figure 6 The relative fractions of autoreactive CD8 T cell epitopes exhibiting cross-reactivity to different categories of antigens of M.
tuberculosis. Bar diagram indicates the relative percentages of HLA class I binders of host-antigens sharing sequence similarity with the different
categories of antigenic proteins of M. tuberculosis.
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Page 7 of 10Figure 7 The peptides identified from host proteins reveal strong HLA class I binding. Bar diagram depicts the percentage of strong
binders (IC50 ≤ 500) among the total identified binders from host-peptides that shared cross-reactivity with M. tuberculosis antigens.
Table 1 Putative CD4 T cell epitopes of established antigens involved in autoimmune diseases that share similarity
with M.tuberculosis proteins.
Protein from
M. tuberculosis.
Disease Homologous Human
Proteins
(known to be
associated with
autoimmunity)
Putative
T cell epitope
HLA Class II Alleles
HSP60 Multiple Sclerosis
[4,18,19,21]
IGAKLVQDVA HLA DRB1* 01:01
HSP60 EGMKFDRGYIS HLA DRB1* 01:01, 03:01,04:01,07:01,11:01,15:01
VAVKAPGFGD HLA DRB1*15:01
KPLVIIAEDVDGEALSTLVLN HLADRB1*01:01,03:01,04:01,07:01,08:02,11:01,13:01,15:01
cDNA FLJ54912 EGMKFNRGYIS HLA DRB1*01: 01, 04: 01, 07: 01, 01: 01, 13: 01, 15: 01
KPLVIIAEDVDGEALSTLV HLA DRB1*01: 01, 03: 01, 04: 01, 07: 01, 08: 02, 11:
01,15: 01
60 kDa chaperonin
(Fragment) [HSPD1]
EGIKFDRGYIS HLA DRB1*01: 01, 03: 01, 04: 01, 07: 01, 08: 02, 11: 01,
13: 01, 15: 01
LKFDRGYVS HLA DRB1*01: 01, 03: 01, 04: 01, 07: 01, 11: 01, 13: 01
Rheumatoid
Arthritis [14,15,17]
Putative
uncharacterized protein
HSPD1
GEALSTLVLN HLA DRB1*01: 01
KPLVIIAEDVDGEALSTLVLN HLA DRB1*01: 01, 03: 01, 04: 01, 07: 01, 08: 02, 11: 01,
13: 01, 15: 01
T-complex protein 1
subunit beta
LALVTGGEI HLA DRB1*01: 01, 07: 01, 13: 01, 15: 01
T-complex protein 1
subunit epsilon
LDKISDSVL HLA DRB1*01: 01, 07: 01
Molybdopterin
biosynthesis Mog
protein
Stiff Man’s
Syndrome [40]
Gephyrin LNLILTTGGTG HLA DRB1*01: 01, 04: 01, 07: 01, 11: 01, 13: 01, 15: 01
Highly similar to
Gephyrin
GKTLIINLPGS HLA DRB1*01: 01, 04: 01, 07: 01, 11: 01, 15: 01
Serine/threonine-
protein kinase
pknD
Paraneoplastic
Limbic
Encephalitis [49]
BR serine/threonine-
protein kinase-2
HRDLKPENLLL HLA DRB1*01: 01, 07: 01, 13: 01
Isoleucyl-tRNA
synthetase
Arthritis [50,51]
SLE [51]
Isoleucyl-tRNA
synthetase
GLPHYGHIL HLA DRB1*01: 01, 15: 01
Interstitial
lung disease
[50,52]
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could contribute pathogenesis of MS [48]. The criteria
for this mechanism includes that the pathogen must be
associated with the onset of the autoimmune reactions,
the antigens from the pathogen must provoke an
immune response that cross-reacts with host proteins.
Further, the cross-reactive epitopes should induce dis-
ease, if tested in an animal model [45]. There are many
reports that act as evidences to satisfy each of these cri-
teria [2,7,44,45].
The presentation of certain antigenic epitopes (that
are mimics of host antigens) to T cells by the pathogen
encountered “TLR licensed” APCs may initiate the auto-
reactive responses [6]. Thus, homologous antigens from
pathogens can potentially “revive” the otherwise non-
responding autoreactive T cells. The inflammatory cyto-
kines present during such priming may also imprint tis-
sue migratory properties. When such autoreactive T
cells come across the “cognate” host antigens, they will
destruct tissues by their effector mechanisms. Hence,
infection not only activates the autoreactive T cells but
also may empower them to migrate to distant tissues
thus initiating a process that ultimately escalates in to a
full-bloomed disease. Tuberculosis has been associated
with autoimmune reactions [13,16]. Classical studies
have demonstrated the occurrence of mycobacterium
reactive T cells that cross-react to antigens associated
with MS, RA, etc [18-21]. Interestingly, in many cases
the antigen was found to be HSP60 [14,18,20]. The pre-
sent study also corroborates with these findings. In addi-
tion, our extensive comparative analysis of the
proteomes of M. tuberculosis and humans followed by T
cell epitope identification has revealed many more such
possible target proteins and their putative epitopes. In
the present scenario, where identifying the etiology of
autoimmune diseases remains a great challenge, we
believe that the outcome of the present study would
open up extensive future investigations into molecular
basis of possible T cell autoimmune reactions during
mycobacterial infections.
Conclusions
In essence, this study indicates the existence of consid-
erable number of potential cross-reactive T cell epitopes
between M. tuberculosis and the human proteome,
which may elicit molecular mimicry and result in auto-
immune responses during M. tuberculosis infection.
Some of the epitopes were promiscuously binding to
predominantly occurring HLA alleles and corroborated
well with established autoimmune diseases. The identi-
fied target proteins and their putative T cell epitopes
may have significant implications that will open up
extensive investigations in understanding the molecular
basis of autoimmune reactions during M. tuberculosis
infection.
Additional material
Additional file 1: List of putative cross reactive epitopes from
human proteome restricted to HLA class II alleles. Data sets represent
a list of human peptide regions showing sequence similarity with M.
tuberculosis. These peptides were assessed for binding to predominant
HLA class I and HLA class II alleles. Based on IC50 values, they were
classified as strong binders (IC50 ≤ 500), weak binders (500 ≤ IC50 ≤ 5000)
and non-binders (IC50 ≥ 5000). Peptides binding to more than three
different alleles were considered as promiscuous.
Additional file 2: List of putative cross reactive epitopes from
human proteome restricted to HLA class I alleles. Data sets represent
a list of human peptide regions showing sequence similarity with M.
tuberculosis. These peptides were assessed for binding to predominant
HLA class I and HLA class II alleles. Based on IC50 values, they were
classified as strong binders (IC50 ≤ 500), weak binders (500 ≤ IC50 ≤ 5000)
and non-binders (IC50 ≥ 5000). Peptides binding to more than three
different alleles were considered as promiscuous.
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